67 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Women with in HIV-AIDS ... or been newly diagnosed ... following initial diagnosis ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Bacterial Enteric Infections ... in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... in HIV-AIDS Treating ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... HIV-AIDS Treating ... • Continue treatment ... #IDSA #Prevention ... #Treatment #management
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
Aspergillus (IA) - Diagnosis ... SOT, Advanced HIV ... /AIDS, CGD) Clinical ... this morphology Treatment ... #Management #treatment
Non-HCV infectious mixed cryoglobulinemia vasculitis - Diagnosis, causes and management - French Vasculitis Study Group

< 5%
Non-HCV infectious ... cryoglobulinemia vasculitis - Diagnosis ... cryoglobulinemia vasculitis Clinical ... neuropathy Treatment ... Cryoglobulinemic #Diagnosis
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... Trypanosomiasis #IDSA ... opportunistic #infections
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... for effective treatment ... candida #mucosal #IDSA ... opportunistic #infections
HIV-Associated Neurocognitive Disorder (HAND)

Definition:
HIV-Associated Neurocognitive disorders categories:
• Asymptomatic neurocognitive impairment
• Mild neurocognitive impairment
• HIV dementia

Pathophysiology:
HIV frequently
early stages of infection ... Diagnosis: MRI ... Clinical Presentation ... : The clinical ... Treatment: • HAART